SEC CIK 1434369
Coleman Glenn
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| XRAYview stock → | 89,767.65 | 2024-10-11 |
| IARTview stock → | 34,622 | 2022-07-01 |
| CRLview stock → | 27,762 | 2026-09-30 |
| CWview stock → | 4,403.45 | 2014-05-12 |
Position History — CW
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CW
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2014-05-12 | Option exercise (derivative) | 4,327 | $0.00 | 5,020 |
| 2014-05-12 | Option exercise (derivative) | 5,020 | $0.00 | 0 |
| 2014-05-12 | Option exercise (derivative) | 3,902 | $0.00 | 9,347 |
| 2014-05-12 | Open-market sale | 13,249 | $69.41 | 4,403.45 |
| 2014-05-12 | Option exercise | 5,020 | $29.88 | 17,652.45 |
| 2014-05-12 | Option exercise | 4,327 | $30.90 | 12,632.45 |
| 2014-05-12 | Option exercise | 3,902 | $30.12 | 8,305.45 |
| 2014-03-20 | Open-market sale | 829 | $62.37 | 4,403.45 |
| 2014-03-19 | Grant / award | 1,654 | $61.91 | 5,232.45 |
| 2014-01-15 | Grant / award | 113.58 | $52.83 | 3,578.45 |
| 2013-11-29 | Grant / award (derivative) | 1,321 | $0.00 | 5,475.75 |
| 2013-11-18 | Open-market sale | 739 | $51.30 | 3,464.87 |
| 2013-11-18 | Option exercise | 1,475 | $51.27 | 4,203.87 |
| 2013-11-15 | Option exercise (derivative) | 1,475 | $0.00 | 4,154.75 |
| 2013-11-05 | Open-market sale | 475.15 | $50.55 | 2,728.87 |
| 2013-11-05 | Open-market sale | 475.15 | $50.55 | 2,728.87 |
| 2013-08-05 | Open-market sale | 714.14 | $44.19 | 3,204.02 |
| 2013-07-11 | Grant / award | 475.15 | $31.57 | 3,918.16 |
| 2013-05-20 | Open-market sale | 346.99 | $36.77 | 3,443.01 |
| 2013-04-02 | Open-market sale | 791 | $33.68 | 3,790.16 |
| 2013-04-02 | Grant / award | 1,544 | $34.70 | 4,581.16 |
| 2013-03-13 | Open-market sale | 373.98 | $34.81 | 3,037.16 |
| 2013-02-08 | Grant / award (derivative) | 2,049 | $0.00 | 5,528 |
| 2013-01-10 | Grant / award | 136.11 | $27.50 | 3,411.14 |
| 2012-11-19 | Option exercise (derivative) | 1,327 | $0.00 | 3,529.92 |
| 2012-11-19 | Option exercise | 1,327 | $29.28 | 3,923.02 |
| 2012-11-19 | Open-market sale | 648 | $29.87 | 3,275.02 |
| 2012-11-14 | Open-market sale | 735.22 | $29.68 | 2,596.02 |
| 2012-07-11 | Grant / award | 578.03 | $25.95 | 3,331.24 |
| 2012-03-27 | Open-market sale | 679 | $37.88 | 2,753.21 |
| 2012-03-27 | Grant / award | 1,396 | $38.04 | 3,432.21 |
| 2012-02-24 | Open-market sale | 281.58 | $38.00 | 2,036.21 |
| 2012-01-12 | Grant / award | 346.99 | $30.26 | 2,317.78 |
| 2011-11-16 | Grant / award (derivative) | 2,048 | $0.00 | 4,766 |
| 2011-11-16 | Open-market sale | 583 | $33.04 | 1,970.78 |
| 2011-11-15 | Open-market sale | 502.51 | $31.86 | 2,553.78 |
| 2011-07-14 | Grant / award | 373.98 | $27.21 | 3,056.29 |
| 2011-02-17 | Open-market sale | 448.01 | $37.46 | 2,682.31 |
| 2011-01-12 | Grant / award | 433.87 | $28.30 | 3,130.32 |
| 2010-11-15 | Grant / award (derivative) | 1,431 | $0.00 | 2,718 |
| 2010-11-15 | Grant / award (derivative) | 5,020 | $0.00 | 13,249 |
| 2010-07-09 | Grant / award | 301.35 | $24.96 | 2,696.45 |
| 2010-01-12 | Grant / award | 281.58 | $25.67 | 2,395.1 |
| 2009-11-18 | Grant / award (derivative) | 4,327 | $0.00 | 8,229 |
| 2009-11-18 | Grant / award (derivative) | 1,287 | $0.00 | 1,287 |
| 2009-07-10 | Grant / award | 502.51 | $25.33 | 2,113.52 |
| 2009-01-14 | Open-market buy | 448.01 | $27.90 | 1,611.01 |
| 2008-11-17 | Grant / award (derivative) | 3,902 | $0.00 | 3,902 |
| 2008-11-17 | Grant / award | 1,163 | $30.12 | 1,163 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.